These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3757849)

  • 1. [Double-blind or open mind?].
    Huttunen JK
    Duodecim; 1986; 102(16):1129-33. PubMed ID: 3757849
    [No Abstract]   [Full Text] [Related]  

  • 2. Guidelines for clinical evaluation of antiepileptic drugs. Commission on Antiepileptic Drugs of the International League Against Epilepsy.
    Epilepsia; 1989; 30(4):400-8. PubMed ID: 2752994
    [No Abstract]   [Full Text] [Related]  

  • 3. [2 treatments with about equal likelihood of a favorable outcome?].
    Rümke CL
    Ned Tijdschr Geneeskd; 1982 Mar; 126(12):529-31. PubMed ID: 7070547
    [No Abstract]   [Full Text] [Related]  

  • 4. [The controlled clinical treatment trial: full of problems, but necessary].
    Wulff HR
    Ugeskr Laeger; 1987 Oct; 149(41):2814-5. PubMed ID: 3451531
    [No Abstract]   [Full Text] [Related]  

  • 5. Double-blinding in clinical trials.
    Ney PG
    CMAJ; 1989 Jan; 140(1):15. PubMed ID: 2909265
    [No Abstract]   [Full Text] [Related]  

  • 6. Perspectives on clinical trials in the rheumatic diseases.
    Hart FD
    Clin Rheum Dis; 1983 Dec; 9(3):491-8. PubMed ID: 6606529
    [No Abstract]   [Full Text] [Related]  

  • 7. Comprehensive pharmacy-based investigational drug service.
    Benfell K; Powell SH; Kaul AF
    Am J Hosp Pharm; 1983 Jan; 40(1):64-7. PubMed ID: 6823990
    [No Abstract]   [Full Text] [Related]  

  • 8. Randomized clinical trial.
    Kupfer C
    Jpn J Ophthalmol; 1982; 26(3):241-7. PubMed ID: 6891416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controversy in counting and attributing events in clinical trials.
    Sackett DL; Gent M
    N Engl J Med; 1979 Dec; 301(26):1410-2. PubMed ID: 514321
    [No Abstract]   [Full Text] [Related]  

  • 10. [Evaluation of clinical trials].
    Gøtzsche PC
    Ugeskr Laeger; 1986 Sep; 148(38):2417-20. PubMed ID: 3765176
    [No Abstract]   [Full Text] [Related]  

  • 11. Immunosuppressive therapy in primary glomerulonephritides (discussion).
    Contrib Nephrol; 1982; (34):64-70. PubMed ID: 6756781
    [No Abstract]   [Full Text] [Related]  

  • 12. Methods for evaluating the therapeutic effect of non-medical treatment.
    Lindahl O
    Scand J Rehabil Med; 1979; 11(4):151-5. PubMed ID: 161068
    [No Abstract]   [Full Text] [Related]  

  • 13. [Use of amino acids as a combination in the treatment of prostatic hypertrophy].
    Menéndez Fernández H; Castillo Vergara P; Hilario García Marcos J; Romero Gil JR
    Arch Esp Urol; 1988 Sep; 41(7):495-9. PubMed ID: 2468315
    [No Abstract]   [Full Text] [Related]  

  • 14. Shortcomings of the National Crohn's Disease Study: the exclusion of azathioprine without adequate trial.
    Korelitz BI; Present DH
    Gastroenterology; 1981 Jan; 80(1):193-6. PubMed ID: 6108892
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparative clinical trials].
    Yokoyama M
    Gan To Kagaku Ryoho; 1984 Mar; 11(3):404-12. PubMed ID: 6703720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical evaluation of ceruletide in schizophrenia: a multi-institutional cooperative double-blind controlled study.
    Itoh H; Shimazono Y; Kawakita Y; Kudo Y; Satoh Y; Takahashi R
    Psychopharmacol Bull; 1986; 22(1):123-8. PubMed ID: 3523572
    [No Abstract]   [Full Text] [Related]  

  • 17. Objective response criteria in phase II and phase III studies.
    Jones WG; Akaza H; Van Oosterom AT; Kotake T
    Prog Clin Biol Res; 1988; 269():243-60. PubMed ID: 3293063
    [No Abstract]   [Full Text] [Related]  

  • 18. Ethical problems in clinical trials concerning minimal residual tumors.
    Dion S; Reizenstein P
    Suppl J Med Oncol Tumor Pharmacother; 1988; 1():99-102. PubMed ID: 3074231
    [No Abstract]   [Full Text] [Related]  

  • 19. Ethical problems in clinical trials concerning minimal residual tumors.
    Dion S; Reizenstein P
    Bull Soc Sci Med Grand Duche Luxemb; 1989; 126(1):99-102. PubMed ID: 2743535
    [No Abstract]   [Full Text] [Related]  

  • 20. Withdrawals from drug trials.
    Pledger G; Hall D
    Biometrics; 1982 Mar; 38(1):276-8. PubMed ID: 7082761
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.